Stem Cell Therapy for Liver Cirrhosis - Prospects and challenges
DOI:
https://doi.org/10.63521/pjg.41.4.2025.17Keywords:
Stem cell, liver cirrhosis.Abstract
The burden of liver diseases and their impact on health is a global concern. While liver transplant remains the curative option for end-stage liver diseases, it has many shortcomings restricting its widespread availability and adaptation. The quest for an effective alternative to slow down progression of liver cirrhosis and restoration of function of cirrhotic liver is therefore ongoing, where stem cell therapy is on the table which. However, although in many cases the results are encouraging with stem cells in liver diseases, it still has a long way to go before it can be recommended in regular clinical practice. We have significant experience of treating liver cirrhosis patients with human progenitor stem cells. Here we present a blend of our own experience and review of recent literature to assess where we stand today with stem cells as an option at our disposal for treating liver diseases.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mamun Al Mahtab (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the Pakistan Journal of Gastroenterology (PJG) the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
